Maternal Inhaled Fluticasone Propionate Intake During Pregnancy is Detected in Neonatal Cord Blood

References

• Kwon HL , TricheEW, BelangerK, BrackenMb. The epidemiology of asthma during pregnancy: prevalence, diagnosis, and symptoms. Immunol. Allergy Clin. North Am. 26 (1), 29–62 (2006).
   PubMed Web of Science ®Google Scholar
• National Heart Lung and Blood Institute . NAEPP expert panel report. Managing asthma during pregnancy: recommendations for pharmacologic treatment-2004 update. J. Allergy Clin. Immunol. 115 (1), 34–46 (2005).
   PubMed Web of Science ®Google Scholar
• Murphy VE , FittockRJ, ZarzyckiPK, DelahuntyMM, SmithR, CliftonVL. Metabolism of synthetic steroids by the human placenta. Placenta28 (1), 39–46 (2007).
   PubMed Web of Science ®Google Scholar
• Tegethoff M , GreeneN, OlsenJ, SchaffnerE, MeinlschmidtG. Inhaled glucocorticoids during pregnancy and offspring pediatric diseases: a national cohort study. Am. J. Respir. Crit. Care Med. 185 (5), 557–563 (2012).
   PubMed Web of Science ®Google Scholar
• Matthews Sg . Early programming of the hypothalamo–pituitary–adrenal axis. Trends Endocrinol. Metab. 13 (9), 373–380 (2002).
   PubMed Web of Science ®Google Scholar
• Krishnaswami S , MollmannH, DerendorfH, HochhausG. A sensitive LC–MS/MS method for the quantification of fluticasone propionate in human plasma. J. Pharm. Biomed. Anal. 22 (1), 123–129 (2000).
   PubMed Web of Science ®Google Scholar
• Mascher Hj , ZechK, MascherDg. Sensitive simultaneous determination of ciclesonide, ciclesonide-M1-metabolite and fluticasone propionate in human serum by HPLC–MS/MS with APPI. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 869 (1–2), 84–92 (2008).
   PubMed Web of Science ®Google Scholar
• Harrison TW , TattersfieldAE. Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjects. Thorax58 (3), 258–260 (2003).
   PubMed Web of Science ®Google Scholar
• Mortimer KJ , TattersfieldAE, TangYet al. Plasma concentrations of fluticasone propionate and budesonide following inhalation: effect of induced bronchoconstriction. Br. J. Clin. Pharmacol. 64 (4), 439–444 (2007).
   PubMed Web of Science ®Google Scholar
• GINA Board of Directors and Science Committee . Global Strategy for Asthma Management and Prevention (2015 update). The GINA reports. www.ginasthma.org.
   Google Scholar
• Lipworth BJ , JacksonCM. Safety of inhaled and intranasal corticosteroids: lessons for the new millennium. Drug Saf. 23 (1), 11–33 (2000).
   PubMed Web of Science ®Google Scholar
• Mesiano S , JaffeRB. Developmental and functional biology of the primate fetal adrenal cortex. Endocr. Rev. 18 (3), 378–403 (1997).
   PubMed Web of Science ®Google Scholar
• Mather J , RainvilleP, GrahamK, PlumbR. A high sensitivity UPLC–MS/MS method for the analysis of fluticasone propionate in plasma. Waters Application note (2009). www.waters.com/webassets/cms/library/docs/720003030en.pdf.
   Google Scholar
• AOAC Guidelines for Single Laboratory Validation of Chemical Methods for Dietary Supplements and Botanicals. AOAC International ; Gaithersburg, MD (2002). www.aoac.org/imis15_prod/AOAC_Docs/StandardsDevelopment/SLV_Guidelines_Dietary_Supplements.pdf.
   Google Scholar
• Rahimi R , NikfarS, AbdollahiM. Meta-analysis finds use of inhaled corticosteroids during pregnancy safe: a systematic meta-analysis review. Hum. Exp. Toxicol. 25 (8), 447–452 (2006).
   PubMed Web of Science ®Google Scholar
• Blais L , BeauchesneMF, LemiereC, ElftouhN. High doses of inhaled corticosteroids during the first trimester of pregnancy and congenital malformations. J. Allergy Clin. Immunol. 124 (6), 1229e1224–1234e1224 (2009).
   Web of Science ®Google Scholar
• Lin S , MunsieJP, Herdt-LosavioMLet al. Maternal asthma medication use and the risk of selected birth defects. Pediatrics129 (2), e317–e324 (2012).
   PubMed Web of Science ®Google Scholar
• Carter SJ , CapkaV. Investigation of interaction between salmeterol and fluticasone propionate and its effect on quantitative accuracy of an LC/MS/MS assay in human plasma at low pg/ml concentrations. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 876 (2), 163–169 (2008).
   PubMed Web of Science ®Google Scholar
• Auray-Blais C , CyrD, NtwariAet al. Urinary globotriaosylceramide excretion correlates with the genotype in children and adults with Fabry disease. Mol. Genet. Metab. 93 (3), 331–340 (2008).
   PubMed Web of Science ®Google Scholar
• Auray-Blais C , BhererP, GagnonRet al. Efficient analysis of urinary glycosaminoglycans by LC–MS/MS in mucopolysaccharidoses type I, II and VI. Mol. Genet. Metab. 102 (1), 49–56 (2011).
   PubMed Web of Science ®Google Scholar
• Auray-Blais C , NtwariA, ClarkeJTet al. How well does urinary lyso-Gb3 function as a biomarker in Fabry disease? Clin. Chim. Acta 411 (23–24), 1906–1914 (2010).
   PubMed Web of Science ®Google Scholar
• Dupont FO , GagnonR, MenardJ, Auray-BlaisC, ArdilouzeJL. Evaluation of the glycemic control in neonates: a novel technical approach for measuring fetal-glycated hemoglobin. J. Perinatol. 31 (12), 807 ; author reply 808 (2011).
   PubMed Web of Science ®Google Scholar
• Auray-Blais C , LavoieP, ZhangHet al. An improved method for glycosaminoglycan analysis by LC–MS/MS of urine samples collected on filter paper. Clin. Chim. Acta413 (7–8), 771–778 (2012).
   PubMed Web of Science ®Google Scholar
• Boutin M , GagnonR, LavoieP, Auray-BlaisC. LC–MS/MS analysis of plasma lyso-Gb3 in Fabry disease. Clin. Chim. Acta414, 273–280 (2012).
   PubMed Web of Science ®Google Scholar
• Lavoie P , BoutinM, Auray-BlaisC. Multiplex analysis of novel urinary lyso-Gb3-related biomarkers for Fabry disease by tandem mass spectrometry. Anal. Chem. 85 (3), 1743–1752 (2013).
   PubMed Web of Science ®Google Scholar
• Boutin M , Auray-BlaisC. Multiplex tandem mass spectrometry analysis of novel plasma lyso-Gb(3)-related analogues in Fabry disease. Anal. Chem. 86 (7), 3476–3483 (2014).
   PubMed Web of Science ®Google Scholar
• Auray-Blais C , MarandaB, LavoieP. High-throughput tandem mass spectrometry multiplex analysis for newborn urinary screening of creatine synthesis and transport disorders, Triple H syndrome and OTC deficiency. Clin. Chim. Acta436, 249–255 (2014).
   PubMed Web of Science ®Google Scholar
• Auray-Blais C , BlaisCM, RamaswamiUet al. Urinary biomarker investigation in children with Fabry disease using tandem mass spectrometry. Clin. Chim. Acta438, 195–204 (2014).
   PubMed Web of Science ®Google Scholar
• Allen A , BareillePJ, RousellVM. Fluticasone furoate, a novel inhaled corticosteroid, demonstrates prolonged lung absorption kinetics in man compared with inhaled fluticasone propionate. Clin. Pharmacokinet. 52 (1), 37–42 (2013).
   PubMed Web of Science ®Google Scholar
• Minto C , LiB, TattamB, BrownK, SealeJP, DonnellyR. Pharmacokinetics of epimeric budesonide and fluticasone propionate after repeat dose inhalation – intersubject variability in systemic absorption from the lung. Br. J. Clin. Pharmacol. 50 (2), 116–124 (2000).
   PubMed Web of Science ®Google Scholar
• Daley-Yates PT , ParkinsDA, ThomasMJ, GillettB, HouseKW, OrtegaHG. Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 microg and fluticasone propionate 250 microg: implications for establishing bioequivalence of inhaled products. Clin. Ther. 31 (2), 370–385 (2009).
   PubMed Web of Science ®Google Scholar
• Moisiadis VG , MatthewsSG. Glucocorticoids and fetal programming part 1: Outcomes. Nat. Rev. Endocrinol. 10 (7), 391–402 (2014).
   PubMed Web of Science ®Google Scholar
• Masoli M , WeatherallM, HoltS, ShirtcliffeP, BeasleyR. Inhaled fluticasone propionate and adrenal effects in adult asthma: systematic review and meta-analysis. Eur. Respir. J. 28 (5), 960–967 (2006).
   PubMed Web of Science ®Google Scholar
• Sheth KK , CookCK, PhilpotEEet al. Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic–pituitary–adrenal-axis function. Allergy Asthma Proc. 25 (2), 115–120 (2004).
   PubMed Web of Science ®Google Scholar
• Wilson AM , LipworthBJ. 24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids. Thorax54 (1), 20–26 (1999).
   PubMed Web of Science ®Google Scholar
• Hodyl NA , StarkMJ, Osei-KumahA, BowmanM, GibsonP, CliftonVL. Fetal glucocorticoid-regulated pathways are not affected by inhaled corticosteroid use for asthma during pregnancy. Am. J. Respir. Crit. Care Med. 183 (6), 716–722 (2011).
   PubMed Web of Science ®Google Scholar
• Cossette B , BeauchesneMF, ForgetAet al. Relative perinatal safety of salmeterol vs formoterol and fluticasone vs budesonide use during pregnancy. Ann. Allergy Asthma Immunol. 112 (5), 459–464 (2014).
   PubMed Web of Science ®Google Scholar